USD10
VKTX Shares
About Viking TherapeuticsViking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
USD10
VKTX Shares
About Viking TherapeuticsViking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$3.3B
OPEN PRICE
$29.57
LOW (1Y)
$22.96
HIGH (1Y)
$43.15
LOW (24H)
$28.04
HIGH (24H)
$29.81
VOLUME (24H)
$2.74M
58.8%
Price history
Time | Price | Change |
|---|---|---|
Today | $29.57 | |
1 Day | $28.45 | 0.00% |
1 Week | $32.83 | |
1 Month | $31.31 | |
1 Year | $27.57 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
